chr6-38918116-C-A
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BP4_ModerateBP6_ModerateBP7
The NM_001206927.2(DNAH8):c.10500C>A(p.Ile3500Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000769 in 1,612,896 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: 𝑓 0.000099   (  0   hom.,  cov: 33) 
 Exomes 𝑓:  0.000075   (  0   hom.  ) 
Consequence
 DNAH8
NM_001206927.2 synonymous
NM_001206927.2 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.589  
Publications
0 publications found 
Genes affected
 DNAH8  (HGNC:2952):  (dynein axonemal heavy chain 8) The protein encoded by this gene is a heavy chain of an axonemal dynein involved in sperm and respiratory cilia motility. Axonemal dyneins generate force through hydrolysis of ATP and binding to microtubules. [provided by RefSeq, Jan 2012] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.28). 
BP6
Variant 6-38918116-C-A is Benign according to our data. Variant chr6-38918116-C-A is described in ClinVar as Likely_benign. ClinVar VariationId is 454535.Status of the report is criteria_provided_single_submitter, 1 stars. 
BP7
Synonymous conserved (PhyloP=0.589 with no splicing effect.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| DNAH8 | NM_001206927.2  | c.10500C>A | p.Ile3500Ile | synonymous_variant | Exon 70 of 93 | ENST00000327475.11 | NP_001193856.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| DNAH8 | ENST00000327475.11  | c.10500C>A | p.Ile3500Ile | synonymous_variant | Exon 70 of 93 | 5 | NM_001206927.2 | ENSP00000333363.7 | ||
| DNAH8 | ENST00000359357.7  | c.9849C>A | p.Ile3283Ile | synonymous_variant | Exon 68 of 91 | 2 | ENSP00000352312.3 | |||
| DNAH8 | ENST00000449981.6  | c.10500C>A | p.Ile3500Ile | synonymous_variant | Exon 69 of 82 | 5 | ENSP00000415331.2 | 
Frequencies
GnomAD3 genomes   AF:  0.0000986  AC: 15AN: 152172Hom.:  0  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
15
AN: 
152172
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.000148  AC: 37AN: 250244 AF XY:  0.000177   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
37
AN: 
250244
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000746  AC: 109AN: 1460724Hom.:  0  Cov.: 30 AF XY:  0.0000922  AC XY: 67AN XY: 726646 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
109
AN: 
1460724
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
67
AN XY: 
726646
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33424
American (AMR) 
 AF: 
AC: 
0
AN: 
44594
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
85
AN: 
26078
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39648
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
86142
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53358
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5764
European-Non Finnish (NFE) 
 AF: 
AC: 
17
AN: 
1111384
Other (OTH) 
 AF: 
AC: 
7
AN: 
60332
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.489 
Heterozygous variant carriers
 0 
 8 
 15 
 23 
 30 
 38 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.0000986  AC: 15AN: 152172Hom.:  0  Cov.: 33 AF XY:  0.000108  AC XY: 8AN XY: 74348 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
15
AN: 
152172
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
8
AN XY: 
74348
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41438
American (AMR) 
 AF: 
AC: 
0
AN: 
15276
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
13
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5198
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4826
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10612
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
1
AN: 
68030
Other (OTH) 
 AF: 
AC: 
1
AN: 
2092
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.495 
Heterozygous variant carriers
 0 
 2 
 4 
 5 
 7 
 9 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Primary ciliary dyskinesia    Benign:1 
Oct 22, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.